Corticosteroid-Dependent Plasticity Mediates Compulsive Alcohol Drinking in Rats
Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during abstinence. We hypothesized that sustained activation of neuroendocrine stress systems (e.g., corticosteroid release via the hypothalamic-pituit...
Saved in:
Published in | The Journal of neuroscience Vol. 32; no. 22; pp. 7563 - 7571 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Society for Neuroscience
30.05.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during abstinence. We hypothesized that sustained activation of neuroendocrine stress systems (e.g., corticosteroid release via the hypothalamic-pituitary-adrenal axis) by alcohol intoxication and withdrawal and consequent alterations in glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation drive compulsive alcohol drinking. Our results showed that rats exposed to alcohol vapor to the point of dependence displayed increased alcohol intake, compulsive drinking measured by progressive-ratio responding, and persistent alcohol consumption despite punishment, assessed by adding quinine to the alcohol solution, compared with control rats that were not exposed to alcohol vapor. No group differences were observed in the self-administration of saccharin-sweetened water. Acute alcohol withdrawal was accompanied by downregulated GR mRNA in various stress/reward-related brain regions [i.e., prefrontal cortex, nucleus accumbens (NAc), and bed nucleus of the stria terminalis (BNST)], whereas protracted alcohol abstinence was accompanied by upregulated GR mRNA in the NAc core, ventral BNST, and central nucleus of the amygdala. No significant alterations in MR mRNA levels were found. Chronic GR antagonism with mifepristone (RU38486) prevented the escalation of alcohol intake and compulsive responding induced by chronic, intermittent alcohol vapor exposure. Chronic treatment with mifepristone also blocked escalated alcohol drinking and compulsive responding during protracted abstinence. Thus, the GR system appears to be involved in the development of alcohol dependence and may represent a potential pharmacological target for the treatment of alcoholism. |
---|---|
AbstractList | Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during abstinence. We hypothesized that sustained activation of neuroendocrine stress systems (e.g., corticosteroid release via the hypothalamic-pituitary-adrenal axis) by alcohol intoxication and withdrawal and consequent alterations in glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation drive compulsive alcohol drinking. Our results showed that rats exposed to alcohol vapor to the point of dependence displayed increased alcohol intake, compulsive drinking measured by progressive-ratio responding, and persistent alcohol consumption despite punishment, assessed by adding quinine to the alcohol solution, compared with control rats that were not exposed to alcohol vapor. No group differences were observed in the self-administration of saccharin-sweetened water. Acute alcohol withdrawal was accompanied by downregulated GR mRNA in various stress/reward-related brain regions [i.e., prefrontal cortex, nucleus accumbens (NAc), and bed nucleus of the stria terminalis (BNST)], whereas protracted alcohol abstinence was accompanied by upregulated GR mRNA in the NAc core, ventral BNST, and central nucleus of the amygdala. No significant alterations in MR mRNA levels were found. Chronic GR antagonism with mifepristone (RU38486) prevented the escalation of alcohol intake and compulsive responding induced by chronic, intermittent alcohol vapor exposure. Chronic treatment with mifepristone also blocked escalated alcohol drinking and compulsive responding during protracted abstinence. Thus, the GR system appears to be involved in the development of alcohol dependence and may represent a potential pharmacological target for the treatment of alcoholism. Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during abstinence. We hypothesized that sustained activation of neuroendocrine stress systems (e.g., corticosteroid release via the hypothalamic-pituitary-adrenal axis) by alcohol intoxication and withdrawal and consequent alterations in glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation drive compulsive alcohol drinking. Our results showed that rats exposed to alcohol vapor to the point of dependence displayed increased alcohol intake, compulsive drinking measured by progressive-ratio responding, and persistent alcohol consumption despite punishment, assessed by adding quinine to the alcohol solution, compared with control rats that were not exposed to alcohol vapor. No group differences were observed in the self-administration of saccharin-sweetened water. Acute alcohol withdrawal was accompanied by downregulated GR mRNA in various stress/reward-related brain regions [i.e., prefrontal cortex, nucleus accumbens (NAc), and bed nucleus of the stria terminalis (BNST)], whereas protracted alcohol abstinence was accompanied by upregulated GR mRNA in the NAc core, ventral BNST, and central nucleus of the amygdala. No significant alterations in MR mRNA levels were found. Chronic GR antagonism with mifepristone (RU38486) prevented the escalation of alcohol intake and compulsive responding induced by chronic, intermittent alcohol vapor exposure. Chronic treatment with mifepristone also blocked escalated alcohol drinking and compulsive responding during protracted abstinence. Thus, the GR system appears to be involved in the development of alcohol dependence and may represent a potential pharmacological target for the treatment of alcoholism.Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during abstinence. We hypothesized that sustained activation of neuroendocrine stress systems (e.g., corticosteroid release via the hypothalamic-pituitary-adrenal axis) by alcohol intoxication and withdrawal and consequent alterations in glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation drive compulsive alcohol drinking. Our results showed that rats exposed to alcohol vapor to the point of dependence displayed increased alcohol intake, compulsive drinking measured by progressive-ratio responding, and persistent alcohol consumption despite punishment, assessed by adding quinine to the alcohol solution, compared with control rats that were not exposed to alcohol vapor. No group differences were observed in the self-administration of saccharin-sweetened water. Acute alcohol withdrawal was accompanied by downregulated GR mRNA in various stress/reward-related brain regions [i.e., prefrontal cortex, nucleus accumbens (NAc), and bed nucleus of the stria terminalis (BNST)], whereas protracted alcohol abstinence was accompanied by upregulated GR mRNA in the NAc core, ventral BNST, and central nucleus of the amygdala. No significant alterations in MR mRNA levels were found. Chronic GR antagonism with mifepristone (RU38486) prevented the escalation of alcohol intake and compulsive responding induced by chronic, intermittent alcohol vapor exposure. Chronic treatment with mifepristone also blocked escalated alcohol drinking and compulsive responding during protracted abstinence. Thus, the GR system appears to be involved in the development of alcohol dependence and may represent a potential pharmacological target for the treatment of alcoholism. |
Author | Whitfield, Timothy W. Sanna, Pietro P. Heilig, Markus Vendruscolo, Leandro F. Zorrilla, Eric P. Koob, George F. Barbier, Estelle Misra, Kaushik K. Rivier, Catherine Repunte-Canonigo, Vez Logrip, Marian L. Schlosburg, Joel E. |
Author_xml | – sequence: 1 givenname: Leandro F. surname: Vendruscolo fullname: Vendruscolo, Leandro F. – sequence: 2 givenname: Estelle surname: Barbier fullname: Barbier, Estelle – sequence: 3 givenname: Joel E. surname: Schlosburg fullname: Schlosburg, Joel E. – sequence: 4 givenname: Kaushik K. surname: Misra fullname: Misra, Kaushik K. – sequence: 5 givenname: Timothy W. surname: Whitfield fullname: Whitfield, Timothy W. – sequence: 6 givenname: Marian L. surname: Logrip fullname: Logrip, Marian L. – sequence: 7 givenname: Catherine surname: Rivier fullname: Rivier, Catherine – sequence: 8 givenname: Vez surname: Repunte-Canonigo fullname: Repunte-Canonigo, Vez – sequence: 9 givenname: Eric P. surname: Zorrilla fullname: Zorrilla, Eric P. – sequence: 10 givenname: Pietro P. surname: Sanna fullname: Sanna, Pietro P. – sequence: 11 givenname: Markus surname: Heilig fullname: Heilig, Markus – sequence: 12 givenname: George F. surname: Koob fullname: Koob, George F. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22649234$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUUtPFTEYbQxGLuhfILN0M9c-pu00MSZkQMGgEJR102m_gWpve23nkvDv6Q2PqBtdfYvz-E7O2UM7MUVA6IDgJeGUvfv89fjq8vzbcLrEWKiW0CXFhL5Ai4qqlnaY7KAFphK3opPdLtor5QfGWGIiX6FdSkWnKOsW6GJIefY2lRly8q49gjVEB3FuLoIpFfHzXfMFnDczlGZIq_UmFH8LzWGw6SaF5ij7-NPH68bH5tLM5TV6OZlQ4M3j3UdXH4-_Dyft2fmn0-HwrLWcsLkVsmeyc8QAjMBGpUbWT4LKUTneCzFRsJa7EbjEDLNpmjjmnDquejupkTq2jz48-K434wqcrZGzCXqd_crkO52M138i0d_o63SrGZNcUFIN3j4a5PRrA2XWK18shGAipE3RhHMiaEf_h4pJz5jClFXqwe-xnvM8NV4J7x8INqdSMky6Vmxmn7Ypfaheejuwfh5YbwfWhOrtwFUu_pI_ffiH8B7ocKxJ |
CitedBy_id | crossref_primary_10_7554_eLife_90422_3 crossref_primary_10_3390_ijms17081271 crossref_primary_10_1111_gbb_12189 crossref_primary_10_1016_j_bcp_2013_07_007 crossref_primary_10_1016_j_neuropharm_2021_108617 crossref_primary_10_1016_j_neuropharm_2022_109309 crossref_primary_10_1186_s12888_016_0757_1 crossref_primary_10_1523_JNEUROSCI_0445_14_2014 crossref_primary_10_1016_j_neuropharm_2020_108337 crossref_primary_10_1007_s00213_015_4033_8 crossref_primary_10_1038_s41598_018_31921_5 crossref_primary_10_1371_journal_pone_0072979 crossref_primary_10_3389_fnbeh_2017_00046 crossref_primary_10_1016_j_neuropharm_2017_04_028 crossref_primary_10_1124_jpet_120_000169 crossref_primary_10_3389_fnbeh_2018_00257 crossref_primary_10_1007_s00213_015_3909_y crossref_primary_10_1016_j_alcohol_2018_04_006 crossref_primary_10_1111_nyas_13989 crossref_primary_10_1016_j_neubiorev_2012_07_010 crossref_primary_10_3389_fpsyt_2016_00165 crossref_primary_10_1523_ENEURO_0153_18_2018 crossref_primary_10_1038_s41583_020_0378_z crossref_primary_10_1523_JNEUROSCI_1673_18_2018 crossref_primary_10_1111_acer_13936 crossref_primary_10_1016_j_ynstr_2023_100539 crossref_primary_10_1111_acer_14900 crossref_primary_10_1016_j_neuropharm_2017_04_031 crossref_primary_10_1016_j_neuropharm_2017_04_032 crossref_primary_10_1016_j_alcohol_2022_09_006 crossref_primary_10_1016_j_neubiorev_2023_105427 crossref_primary_10_3390_brainsci12081042 crossref_primary_10_1093_alcalc_agz022 crossref_primary_10_2139_ssrn_4122362 crossref_primary_10_1016_j_neuropharm_2013_04_036 crossref_primary_10_1038_s41386_018_0055_3 crossref_primary_10_1007_s00424_013_1266_4 crossref_primary_10_1016_j_neures_2020_01_002 crossref_primary_10_1164_rccm_202108_1845ST crossref_primary_10_1111_adb_12758 crossref_primary_10_1016_j_neuropharm_2021_108510 crossref_primary_10_1016_j_psyneuen_2017_06_006 crossref_primary_10_1016_j_neuropharm_2020_108438 crossref_primary_10_3390_ijms22063095 crossref_primary_10_3389_adar_2023_10871 crossref_primary_10_1523_JNEUROSCI_1395_16_2016 crossref_primary_10_1038_s41380_022_01501_1 crossref_primary_10_1093_alcalc_agaa068 crossref_primary_10_4103_NRR_NRR_D_24_00355 crossref_primary_10_1111_adb_13158 crossref_primary_10_1111_acer_14129 crossref_primary_10_1523_JNEUROSCI_4571_14_2015 crossref_primary_10_1523_JNEUROSCI_3302_14_2015 crossref_primary_10_3390_metabo13010062 crossref_primary_10_1016_j_pbb_2021_173290 crossref_primary_10_1007_s00213_024_06707_5 crossref_primary_10_32345_2664_4738_1_2021_01 crossref_primary_10_1016_j_alcohol_2013_05_003 crossref_primary_10_1111_adb_12187 crossref_primary_10_1007_s00213_018_4905_9 crossref_primary_10_1016_j_pharmthera_2017_11_007 crossref_primary_10_1016_j_alcohol_2019_01_006 crossref_primary_10_1016_j_neubiorev_2019_10_009 crossref_primary_10_1016_j_neuroscience_2015_02_043 crossref_primary_10_1093_cercor_bhy341 crossref_primary_10_1016_j_alcohol_2015_03_001 crossref_primary_10_1111_acer_15006 crossref_primary_10_3389_fnbeh_2022_821859 crossref_primary_10_1093_alcalc_agz054 crossref_primary_10_1007_s00213_017_4608_7 crossref_primary_10_1016_j_bbr_2021_113295 crossref_primary_10_1111_acer_12093 crossref_primary_10_1016_j_bcp_2015_07_038 crossref_primary_10_1146_annurev_pharmtox_010715_103143 crossref_primary_10_1016_j_neuroscience_2014_06_053 crossref_primary_10_1016_j_neuropharm_2019_107669 crossref_primary_10_1111_adb_12289 crossref_primary_10_1111_jnc_15342 crossref_primary_10_1016_j_neuropharm_2020_108396 crossref_primary_10_1007_s00213_014_3665_4 crossref_primary_10_1111_adb_13138 crossref_primary_10_1007_s00429_015_1163_z crossref_primary_10_1111_acer_14260 crossref_primary_10_3389_fnbeh_2019_00292 crossref_primary_10_1016_j_alcohol_2013_08_006 crossref_primary_10_3390_brainsci10100682 crossref_primary_10_3389_fphar_2022_927703 crossref_primary_10_1016_j_cobeha_2016_10_006 crossref_primary_10_1038_npp_2017_105 crossref_primary_10_1111_adb_12150 crossref_primary_10_1016_j_neuropharm_2016_08_008 crossref_primary_10_1016_j_bbr_2014_06_003 crossref_primary_10_1016_j_neuropharm_2015_06_017 crossref_primary_10_1038_mp_2017_97 crossref_primary_10_1016_j_taap_2017_02_003 crossref_primary_10_1111_adb_12829 crossref_primary_10_1186_s13059_015_0593_5 crossref_primary_10_1124_pharmrev_120_000083 crossref_primary_10_3389_fpsyt_2019_00580 crossref_primary_10_1111_acer_12547 crossref_primary_10_1016_j_neuron_2013_06_006 crossref_primary_10_1016_j_pbb_2016_08_001 crossref_primary_10_1016_j_yfrne_2014_01_001 crossref_primary_10_1038_npp_2014_293 crossref_primary_10_1089_jcr_2013_0003 crossref_primary_10_1007_s00213_016_4484_6 crossref_primary_10_1038_tp_2013_70 crossref_primary_10_1111_gbb_12344 crossref_primary_10_1038_npp_2012_261 crossref_primary_10_1038_s41386_022_01497_w crossref_primary_10_1016_j_pbb_2018_07_011 crossref_primary_10_1111_gbb_12349 crossref_primary_10_3109_10253890_2013_872617 crossref_primary_10_3390_ijms21124411 crossref_primary_10_1016_j_neuroscience_2020_04_033 crossref_primary_10_1016_j_alcohol_2018_02_002 crossref_primary_10_1007_s11062_013_9354_9 crossref_primary_10_1111_adb_12937 crossref_primary_10_1016_j_neuropharm_2022_108980 crossref_primary_10_1111_acer_13303 crossref_primary_10_1016_j_brainres_2016_01_049 crossref_primary_10_1038_tp_2016_13 crossref_primary_10_1016_j_pnpbp_2017_09_003 crossref_primary_10_1038_mp_2016_131 crossref_primary_10_1016_j_pharmthera_2022_108299 crossref_primary_10_1016_j_neulet_2017_04_063 crossref_primary_10_1002_jeab_834 crossref_primary_10_1007_s00213_018_4855_2 crossref_primary_10_1038_s41386_018_0101_1 crossref_primary_10_1016_j_ejphar_2014_11_044 crossref_primary_10_1016_j_biopsych_2020_08_027 crossref_primary_10_1016_j_bbr_2019_02_015 crossref_primary_10_1016_j_pbb_2018_03_001 crossref_primary_10_1111_adb_12125 crossref_primary_10_1016_j_pbb_2020_172880 crossref_primary_10_1016_j_neuropharm_2022_109044 crossref_primary_10_1016_j_addicn_2022_100028 crossref_primary_10_3390_ijms241512233 crossref_primary_10_1007_s10571_018_0614_5 crossref_primary_10_1016_j_addicn_2022_100057 crossref_primary_10_1016_j_tins_2018_08_005 crossref_primary_10_1016_j_cobeha_2016_11_004 crossref_primary_10_1007_s00213_021_05770_6 crossref_primary_10_1007_s00213_017_4556_2 crossref_primary_10_1016_j_neuropharm_2019_107857 crossref_primary_10_7554_eLife_90422 crossref_primary_10_1177_02698811241230255 crossref_primary_10_3109_15622975_2014_916414 crossref_primary_10_1016_j_nlm_2013_06_017 crossref_primary_10_1038_nrn_2016_67 crossref_primary_10_1097_FBP_0000000000000304 crossref_primary_10_1016_j_alcohol_2015_04_006 crossref_primary_10_1016_j_alcohol_2015_04_004 crossref_primary_10_1016_j_neuropharm_2023_109635 crossref_primary_10_3390_brainsci11010062 crossref_primary_10_1523_JNEUROSCI_4062_12_2013 crossref_primary_10_1111_adb_12342 crossref_primary_10_1080_00952990_2016_1197232 crossref_primary_10_1111_acer_13434 crossref_primary_10_1111_acer_13555 crossref_primary_10_1111_adb_12349 crossref_primary_10_3390_brainsci9120367 crossref_primary_10_1016_j_alcohol_2014_09_002 crossref_primary_10_1073_pnas_1506012113 crossref_primary_10_1016_j_brainres_2020_146921 crossref_primary_10_1186_s13293_021_00395_y crossref_primary_10_4303_jdar_236039 crossref_primary_10_1016_j_conb_2013_03_006 crossref_primary_10_1002_jnr_24932 crossref_primary_10_1111_acer_14318 crossref_primary_10_1016_j_alcohol_2014_03_001 crossref_primary_10_1016_j_alcohol_2018_05_014 crossref_primary_10_1177_2470547017698140 crossref_primary_10_1016_j_nlm_2024_107944 crossref_primary_10_1016_j_ynstr_2024_100609 crossref_primary_10_1371_journal_pbio_2006421 crossref_primary_10_1016_j_neuropharm_2013_05_024 crossref_primary_10_1523_JNEUROSCI_1027_24_2024 crossref_primary_10_1016_j_neuropharm_2022_109074 crossref_primary_10_1038_s41380_024_02514_8 crossref_primary_10_3389_fnins_2022_858427 crossref_primary_10_1016_j_mcn_2015_03_008 crossref_primary_10_1016_j_drugalcdep_2015_06_018 crossref_primary_10_1016_j_physbeh_2015_05_034 crossref_primary_10_1016_j_biopsych_2014_09_008 crossref_primary_10_1007_s00429_014_0755_3 crossref_primary_10_1016_j_neubiorev_2018_09_008 crossref_primary_10_1016_j_drugalcdep_2012_12_017 crossref_primary_10_1523_JNEUROSCI_2466_16_2017 crossref_primary_10_1016_j_alcohol_2015_11_010 crossref_primary_10_3390_brainsci8070119 crossref_primary_10_1007_s00213_022_06192_8 crossref_primary_10_1038_s41380_022_01934_8 crossref_primary_10_1007_s00213_014_3623_1 crossref_primary_10_3390_ijms22084184 crossref_primary_10_1038_npp_2014_55 crossref_primary_10_1080_13543784_2018_1502269 crossref_primary_10_1016_j_neuroscience_2012_10_052 crossref_primary_10_1016_j_bbr_2022_114032 crossref_primary_10_1016_j_alcohol_2016_07_008 crossref_primary_10_1016_j_nbd_2022_105610 crossref_primary_10_1016_j_bbr_2012_12_035 crossref_primary_10_1016_j_ynstr_2023_100547 crossref_primary_10_1016_j_neubiorev_2018_09_010 crossref_primary_10_1016_j_physbeh_2018_04_001 crossref_primary_10_1111_acer_13923 crossref_primary_10_1038_npp_2014_20 crossref_primary_10_1016_j_alcohol_2025_03_003 crossref_primary_10_1111_acer_13484 crossref_primary_10_1016_j_neuropharm_2017_03_027 crossref_primary_10_1038_s41380_019_0449_6 crossref_primary_10_1007_s00213_020_05722_6 crossref_primary_10_1016_j_psc_2015_05_009 crossref_primary_10_1111_adb_12429 crossref_primary_10_1016_j_drugalcdep_2019_107657 crossref_primary_10_1016_j_neuropharm_2017_03_028 crossref_primary_10_1111_acer_12269 crossref_primary_10_1016_j_nlm_2024_107955 crossref_primary_10_1172_JCI79828 crossref_primary_10_1038_s41386_024_01988_y crossref_primary_10_1016_j_celrep_2024_114474 crossref_primary_10_1038_s41386_019_0538_x crossref_primary_10_3389_fphar_2014_00279 crossref_primary_10_1007_s00213_016_4257_2 |
Cites_doi | 10.1021/bi901956s 10.1016/S0306-4530(97)00027-9 10.1016/j.cct.2009.03.001 10.1210/me.2002-0144 10.1007/s002130100773 10.1523/JNEUROSCI.17-22-08856.1997 10.1158/1541-7786.MCR-11-0423-T 10.1007/BF02805986 10.1080/10253890400019672 10.1111/j.1530-0277.2007.00456.x 10.1111/j.1530-0277.2007.00444.x 10.1016/j.brainresbull.2005.08.006 10.15288/jsa.2003.64.445 10.1097/00000374-199812000-00023 10.1111/j.1530-0277.2002.tb02448.x 10.1210/me.2007-0360 10.1097/01.ALC.0000145781.11923.4E 10.1210/me.2007-0219 10.1038/npp.2009.110 10.1152/physrev.00041.2006 10.1111/j.1530-0277.2008.00799.x 10.1016/S0022-3565(25)12130-7 10.1016/j.neuropharm.2011.11.006 10.1111/j.1460-9568.2007.05972.x 10.1016/S0022-3565(25)27369-4 10.1111/j.1460-9568.2008.06455.x 10.1038/npp.2011.268 10.1371/journal.pone.0009296 10.3109/07853899309147861 10.1210/me.2004-0528 10.1016/S0022-3565(24)37765-1 10.1111/j.1530-0277.2000.tb02036.x 10.1007/978-3-642-28720-6_129 10.1097/01.ALC.0000087581.13912.64 10.1038/sj.npp.1300884 10.1111/j.1530-0277.2000.tb01988.x 10.1001/archpsyc.1990.01810160025004 10.1523/JNEUROSCI.3136-11.2012 10.1007/BF02245190 10.1073/pnas.0402208101 10.1016/j.biopsych.2007.01.010 10.1074/jbc.M106033200 10.1016/j.lfs.2005.01.013 10.1016/j.psyneuen.2003.09.004 10.1111/j.1369-1600.2008.00131.x 10.1016/S0091-3057(02)00791-8 10.1038/npp.2009.209 10.1073/pnas.0130100100 10.1016/0022-4731(88)90133-1 10.1073/pnas.92.13.5880 10.1111/j.1530-0277.2006.00259.x 10.1210/en.2010-0266 10.1111/j.1530-0277.2008.00632.x 10.1001/archgenpsychiatry.2011.49 10.2217/fnl.10.14 10.1111/j.1601-183X.2007.00345.x 10.1210/en.2010-0832 10.1111/j.1530-0277.1986.tb05120.x 10.1016/j.tins.2007.06.006 10.1126/science.134.3483.943 10.1111/j.1530-0277.2009.01051.x 10.1038/nrn1683 10.1016/S0165-6147(97)01115-2 10.1016/S0893-133X(99)00167-0 10.1074/jbc.M110.193672 10.1523/JNEUROSCI.0736-05.2005 10.1016/S0303-7207(98)00208-1 10.1016/j.yfrne.2004.07.001 10.1038/220911a0 10.1111/j.1530-0277.2008.00678.x 10.1016/0166-4328(95)00131-C 10.1128/MCB.05866-11 10.1002/dev.20324 10.1074/jbc.274.2.1005 |
ContentType | Journal Article |
Copyright | Copyright © 2012 the authors 0270-6474/12/327563-09$15.00/0 2012 |
Copyright_xml | – notice: Copyright © 2012 the authors 0270-6474/12/327563-09$15.00/0 2012 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7TK 5PM |
DOI | 10.1523/JNEUROSCI.0069-12.2012 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Neurosciences Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1529-2401 |
EndPage | 7571 |
ExternalDocumentID | PMC3375621 22649234 10_1523_JNEUROSCI_0069_12_2012 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: GM085659 – fundername: NIAAA NIH HHS grantid: F32AA018914 – fundername: NIAAA NIH HHS grantid: T32AA007456 – fundername: NIAAA NIH HHS grantid: T32 AA007456 – fundername: NIAAA NIH HHS grantid: F32 AA018914 – fundername: NIAAA NIH HHS grantid: R01 AA017371 – fundername: NIAAA NIH HHS grantid: AA017371 – fundername: NIDA NIH HHS grantid: DA004043 – fundername: NIAAA NIH HHS grantid: P50 AA006420 – fundername: NIAAA NIH HHS grantid: AA006420 |
GroupedDBID | --- -DZ -~X .55 18M 2WC 34G 39C 3O- 53G 5GY 5RE 5VS AAFWJ AAJMC AAYXX ABBAR ABIVO ACGUR ACNCT ADBBV ADCOW ADHGD AENEX AETEA AFCFT AFOSN AFSQR AHWXS ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CITATION CS3 DIK DU5 E3Z EBS EJD F5P GX1 H13 HYE H~9 KQ8 L7B MVM OK1 P0W P2P QZG R.V RHI RPM TFN TR2 W8F WH7 WOQ X7M XJT YBU YHG YKV YNH YSK AFHIN AIZTS CGR CUY CVF ECM EIF NPM RHF 7X8 7TK 5PM |
ID | FETCH-LOGICAL-c513t-678374d1aeebe3b99b38f627b9d5866f2ecc5dbe570303fff50552d598cf9b2d3 |
ISSN | 0270-6474 1529-2401 |
IngestDate | Thu Aug 21 18:28:26 EDT 2025 Fri Jul 11 12:25:17 EDT 2025 Thu Jul 10 22:01:14 EDT 2025 Wed Feb 19 02:35:46 EST 2025 Tue Jul 01 05:18:51 EDT 2025 Thu Apr 24 23:06:19 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 22 |
Language | English |
License | https://creativecommons.org/licenses/by-nc-sa/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c513t-678374d1aeebe3b99b38f627b9d5866f2ecc5dbe570303fff50552d598cf9b2d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: L.F.V., E.P.Z., M.H., and G.F.K. designed research; L.F.V., E.B., J.E.S., K.K.M., T.W.W., M.L.L., V.R.-C., and P.P.S. performed research; L.F.V., E.B., C.R., V.R.-C., E.P.Z., P.P.S., M.H., and G.F.K. analyzed data; L.F.V., E.P.Z., M.H., and G.F.K. wrote the paper. |
OpenAccessLink | https://www.jneurosci.org/content/jneuro/32/22/7563.full.pdf |
PMID | 22649234 |
PQID | 1018339023 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3375621 proquest_miscellaneous_1551624221 proquest_miscellaneous_1018339023 pubmed_primary_22649234 crossref_citationtrail_10_1523_JNEUROSCI_0069_12_2012 crossref_primary_10_1523_JNEUROSCI_0069_12_2012 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-05-30 2012-May-30 20120530 |
PublicationDateYYYYMMDD | 2012-05-30 |
PublicationDate_xml | – month: 05 year: 2012 text: 2012-05-30 day: 30 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of neuroscience |
PublicationTitleAlternate | J Neurosci |
PublicationYear | 2012 |
Publisher | Society for Neuroscience |
Publisher_xml | – name: Society for Neuroscience |
References | Fahlke (2023041303563928000_32.22.7563.16) 1996; 127 Peeters (2023041303563928000_32.22.7563.47) 2004; 7 Mantsch (2023041303563928000_32.22.7563.37) 1998; 287 2023041303563928000_32.22.7563.40 2023041303563928000_32.22.7563.41 2023041303563928000_32.22.7563.43 Rimondini (2023041303563928000_32.22.7563.54) 2003; 64 2023041303563928000_32.22.7563.48 2023041303563928000_32.22.7563.49 2023041303563928000_32.22.7563.44 2023041303563928000_32.22.7563.45 Nihalani (2023041303563928000_32.22.7563.42) 2007; 8 Oomen (2023041303563928000_32.22.7563.46) 2007; 26 2023041303563928000_32.22.7563.51 2023041303563928000_32.22.7563.52 2023041303563928000_32.22.7563.53 2023041303563928000_32.22.7563.10 2023041303563928000_32.22.7563.50 2023041303563928000_32.22.7563.4 2023041303563928000_32.22.7563.15 2023041303563928000_32.22.7563.59 2023041303563928000_32.22.7563.5 2023041303563928000_32.22.7563.6 2023041303563928000_32.22.7563.17 2023041303563928000_32.22.7563.7 2023041303563928000_32.22.7563.18 2023041303563928000_32.22.7563.11 2023041303563928000_32.22.7563.55 2023041303563928000_32.22.7563.1 2023041303563928000_32.22.7563.12 Heikinheimo (2023041303563928000_32.22.7563.22) 1993; 25 2023041303563928000_32.22.7563.2 2023041303563928000_32.22.7563.13 Roberts (2023041303563928000_32.22.7563.56) 1995; 275 2023041303563928000_32.22.7563.57 2023041303563928000_32.22.7563.3 2023041303563928000_32.22.7563.58 2023041303563928000_32.22.7563.8 2023041303563928000_32.22.7563.19 2023041303563928000_32.22.7563.9 2023041303563928000_32.22.7563.62 2023041303563928000_32.22.7563.63 2023041303563928000_32.22.7563.20 2023041303563928000_32.22.7563.64 2023041303563928000_32.22.7563.21 2023041303563928000_32.22.7563.65 2023041303563928000_32.22.7563.60 2023041303563928000_32.22.7563.61 2023041303563928000_32.22.7563.26 2023041303563928000_32.22.7563.27 2023041303563928000_32.22.7563.28 2023041303563928000_32.22.7563.29 2023041303563928000_32.22.7563.66 2023041303563928000_32.22.7563.23 2023041303563928000_32.22.7563.67 2023041303563928000_32.22.7563.24 2023041303563928000_32.22.7563.68 2023041303563928000_32.22.7563.25 2023041303563928000_32.22.7563.69 2023041303563928000_32.22.7563.73 2023041303563928000_32.22.7563.30 2023041303563928000_32.22.7563.74 2023041303563928000_32.22.7563.31 2023041303563928000_32.22.7563.75 2023041303563928000_32.22.7563.76 2023041303563928000_32.22.7563.70 2023041303563928000_32.22.7563.71 2023041303563928000_32.22.7563.72 Lee (2023041303563928000_32.22.7563.32) 1997; 17 2023041303563928000_32.22.7563.38 2023041303563928000_32.22.7563.39 Ellis (2023041303563928000_32.22.7563.14) 1966; 153 2023041303563928000_32.22.7563.33 2023041303563928000_32.22.7563.34 2023041303563928000_32.22.7563.35 2023041303563928000_32.22.7563.36 |
References_xml | – ident: 2023041303563928000_32.22.7563.4 doi: 10.1021/bi901956s – ident: 2023041303563928000_32.22.7563.21 doi: 10.1016/S0306-4530(97)00027-9 – ident: 2023041303563928000_32.22.7563.5 doi: 10.1016/j.cct.2009.03.001 – ident: 2023041303563928000_32.22.7563.25 doi: 10.1210/me.2002-0144 – ident: 2023041303563928000_32.22.7563.76 doi: 10.1007/s002130100773 – volume: 17 start-page: 8856 year: 1997 ident: 2023041303563928000_32.22.7563.32 article-title: An initial, three-day-long treatment with alcohol induces a long-lasting phenomenon of selective tolerance in the activity of the rat hypothalamic-pituitary-adrenal axis publication-title: J Neurosci doi: 10.1523/JNEUROSCI.17-22-08856.1997 – ident: 2023041303563928000_32.22.7563.55 doi: 10.1158/1541-7786.MCR-11-0423-T – volume: 127 start-page: 133 year: 1996 ident: 2023041303563928000_32.22.7563.16 article-title: Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone publication-title: Psychopharmacology (Berl) doi: 10.1007/BF02805986 – volume: 7 start-page: 233 year: 2004 ident: 2023041303563928000_32.22.7563.47 article-title: Glucocorticoid receptor antagonists: new tools to investigate disorders characterized by cortisol hypersecretion publication-title: Stress doi: 10.1080/10253890400019672 – ident: 2023041303563928000_32.22.7563.75 doi: 10.1111/j.1530-0277.2007.00456.x – ident: 2023041303563928000_32.22.7563.33 doi: 10.1111/j.1530-0277.2007.00444.x – ident: 2023041303563928000_32.22.7563.44 doi: 10.1016/j.brainresbull.2005.08.006 – volume: 64 start-page: 445 year: 2003 ident: 2023041303563928000_32.22.7563.54 article-title: A temporal threshold for induction of persistent alcohol preference: behavioral evidence in a rat model of intermittent intoxication publication-title: J Stud Alcohol doi: 10.15288/jsa.2003.64.445 – ident: 2023041303563928000_32.22.7563.28 doi: 10.1097/00000374-199812000-00023 – ident: 2023041303563928000_32.22.7563.66 doi: 10.1111/j.1530-0277.2002.tb02448.x – ident: 2023041303563928000_32.22.7563.9 doi: 10.1210/me.2007-0360 – ident: 2023041303563928000_32.22.7563.45 doi: 10.1097/01.ALC.0000145781.11923.4E – ident: 2023041303563928000_32.22.7563.6 doi: 10.1210/me.2007-0219 – ident: 2023041303563928000_32.22.7563.31 doi: 10.1038/npp.2009.110 – ident: 2023041303563928000_32.22.7563.38 doi: 10.1152/physrev.00041.2006 – ident: 2023041303563928000_32.22.7563.26 doi: 10.1111/j.1530-0277.2008.00799.x – volume: 275 start-page: 790 year: 1995 ident: 2023041303563928000_32.22.7563.56 article-title: Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)12130-7 – ident: 2023041303563928000_32.22.7563.12 doi: 10.1016/j.neuropharm.2011.11.006 – volume: 26 start-page: 3395 year: 2007 ident: 2023041303563928000_32.22.7563.46 article-title: Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2007.05972.x – volume: 153 start-page: 121 year: 1966 ident: 2023041303563928000_32.22.7563.14 article-title: Effect of ethanol on plasma corticosterone levels publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)27369-4 – ident: 2023041303563928000_32.22.7563.52 doi: 10.1111/j.1460-9568.2008.06455.x – ident: 2023041303563928000_32.22.7563.62 doi: 10.1038/npp.2011.268 – ident: 2023041303563928000_32.22.7563.67 doi: 10.1371/journal.pone.0009296 – volume: 25 start-page: 71 year: 1993 ident: 2023041303563928000_32.22.7563.22 article-title: Dose-response relationships of RU 486 publication-title: Ann Med doi: 10.3109/07853899309147861 – ident: 2023041303563928000_32.22.7563.40 doi: 10.1210/me.2004-0528 – volume: 287 start-page: 72 year: 1998 ident: 2023041303563928000_32.22.7563.37 article-title: Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type II glucocorticoid receptor agonist dexamethasone publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)37765-1 – ident: 2023041303563928000_32.22.7563.34 doi: 10.1111/j.1530-0277.2000.tb02036.x – ident: 2023041303563928000_32.22.7563.30 doi: 10.1007/978-3-642-28720-6_129 – ident: 2023041303563928000_32.22.7563.2 doi: 10.1097/01.ALC.0000087581.13912.64 – ident: 2023041303563928000_32.22.7563.17 doi: 10.1038/sj.npp.1300884 – ident: 2023041303563928000_32.22.7563.50 doi: 10.1111/j.1530-0277.2000.tb01988.x – ident: 2023041303563928000_32.22.7563.1 doi: 10.1001/archpsyc.1990.01810160025004 – ident: 2023041303563928000_32.22.7563.49 doi: 10.1523/JNEUROSCI.3136-11.2012 – ident: 2023041303563928000_32.22.7563.15 doi: 10.1007/BF02245190 – ident: 2023041303563928000_32.22.7563.71 doi: 10.1073/pnas.0402208101 – ident: 2023041303563928000_32.22.7563.7 – ident: 2023041303563928000_32.22.7563.64 doi: 10.1016/j.biopsych.2007.01.010 – ident: 2023041303563928000_32.22.7563.70 doi: 10.1074/jbc.M106033200 – ident: 2023041303563928000_32.22.7563.8 doi: 10.1016/j.lfs.2005.01.013 – ident: 2023041303563928000_32.22.7563.29 doi: 10.1016/j.psyneuen.2003.09.004 – ident: 2023041303563928000_32.22.7563.65 doi: 10.1111/j.1369-1600.2008.00131.x – ident: 2023041303563928000_32.22.7563.36 doi: 10.1016/S0091-3057(02)00791-8 – ident: 2023041303563928000_32.22.7563.35 doi: 10.1038/npp.2009.209 – ident: 2023041303563928000_32.22.7563.60 doi: 10.1073/pnas.0130100100 – ident: 2023041303563928000_32.22.7563.3 doi: 10.1016/0022-4731(88)90133-1 – ident: 2023041303563928000_32.22.7563.61 doi: 10.1073/pnas.92.13.5880 – ident: 2023041303563928000_32.22.7563.69 doi: 10.1111/j.1530-0277.2006.00259.x – ident: 2023041303563928000_32.22.7563.43 doi: 10.1210/en.2010-0266 – ident: 2023041303563928000_32.22.7563.73 doi: 10.1111/j.1530-0277.2008.00632.x – ident: 2023041303563928000_32.22.7563.63 doi: 10.1001/archgenpsychiatry.2011.49 – ident: 2023041303563928000_32.22.7563.11 doi: 10.2217/fnl.10.14 – ident: 2023041303563928000_32.22.7563.27 doi: 10.1111/j.1601-183X.2007.00345.x – ident: 2023041303563928000_32.22.7563.59 doi: 10.1210/en.2010-0832 – ident: 2023041303563928000_32.22.7563.58 doi: 10.1111/j.1530-0277.1986.tb05120.x – volume: 8 start-page: 563 year: 2007 ident: 2023041303563928000_32.22.7563.42 article-title: Mifepristone, a glucocorticoid antagonist for the potential treatment of psychotic major depression publication-title: Curr Opin Investig Drugs – ident: 2023041303563928000_32.22.7563.23 doi: 10.1016/j.tins.2007.06.006 – ident: 2023041303563928000_32.22.7563.24 doi: 10.1126/science.134.3483.943 – ident: 2023041303563928000_32.22.7563.20 doi: 10.1111/j.1530-0277.2009.01051.x – ident: 2023041303563928000_32.22.7563.10 doi: 10.1038/nrn1683 – ident: 2023041303563928000_32.22.7563.48 doi: 10.1016/S0165-6147(97)01115-2 – ident: 2023041303563928000_32.22.7563.57 doi: 10.1016/S0893-133X(99)00167-0 – ident: 2023041303563928000_32.22.7563.68 doi: 10.1074/jbc.M110.193672 – ident: 2023041303563928000_32.22.7563.53 doi: 10.1523/JNEUROSCI.0736-05.2005 – ident: 2023041303563928000_32.22.7563.51 doi: 10.1016/S0303-7207(98)00208-1 – ident: 2023041303563928000_32.22.7563.74 doi: 10.1016/j.yfrne.2004.07.001 – ident: 2023041303563928000_32.22.7563.39 doi: 10.1038/220911a0 – ident: 2023041303563928000_32.22.7563.19 doi: 10.1111/j.1530-0277.2008.00678.x – ident: 2023041303563928000_32.22.7563.72 doi: 10.1016/0166-4328(95)00131-C – ident: 2023041303563928000_32.22.7563.18 doi: 10.1128/MCB.05866-11 – ident: 2023041303563928000_32.22.7563.41 doi: 10.1002/dev.20324 – ident: 2023041303563928000_32.22.7563.13 doi: 10.1074/jbc.274.2.1005 |
SSID | ssj0007017 |
Score | 2.52416 |
Snippet | Alcoholism is characterized by a compulsion to seek and ingest alcohol, loss of control over intake, and the emergence of a negative emotional state during... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 7563 |
SubjectTerms | Alcohol Drinking - drug therapy Alcohol Drinking - metabolism Alcohol Drinking - pathology Analysis of Variance Animals Behavior, Addictive - drug therapy Behavior, Addictive - metabolism Brain - metabolism Central Nervous System Depressants - administration & dosage Compulsive Behavior - physiopathology Conditioning, Operant - drug effects Ethanol - administration & dosage Hormone Antagonists - therapeutic use Male Mifepristone - therapeutic use Rats Rats, Wistar Receptors, Glucocorticoid - genetics Receptors, Glucocorticoid - metabolism Receptors, Mineralocorticoid - genetics Receptors, Mineralocorticoid - metabolism Reinforcement Schedule RNA, Messenger - metabolism Self Administration Substance Withdrawal Syndrome - drug therapy Substance Withdrawal Syndrome - metabolism Up-Regulation - drug effects |
Title | Corticosteroid-Dependent Plasticity Mediates Compulsive Alcohol Drinking in Rats |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22649234 https://www.proquest.com/docview/1018339023 https://www.proquest.com/docview/1551624221 https://pubmed.ncbi.nlm.nih.gov/PMC3375621 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgvPCCgPFRvmQkxAsKS-w4Th6natMYWwHRor5F-bIarSSoSR7gr-fOceKVFRi8RJWb1JHvfP2d7353hLxyCwANnqucVAlwULC1SSqZcgC5ZjxMlC91L4LzWXCy8E-XYmlTgjS7pE3fZj928kr-R6owBnJFluw_SHb8URiAzyBfuIKE4XotGU9rHEOaxqYuc2doaNtib2isv4wIW1ND8HAVk8e7tc5WT_q-uG_yTd85QZNakr6m04BULWdMo9VLdS9HVfgCs226Butea_e-SLD6gc0VxlhGafg0jWar2LDPal03GOHpT_CLtWVEnJfNxvDUumZVXpiDWHMygSkeYgiyGGPKdPSm151ix5ixwPaEsxtoysaeStGbvyuGXuiCE6czzHf8PH2H6XnY1gFz9Zj9axvC-bMP8fHi7CyeHy3nN8ktBi4F2sT3n2xleenq7szj-xk2OcxzsHuWbSBzxTv5Ncn2EmqZ3yV3jADpYa8798iNorpP9g-rpK2_fqevqU4A1pGVffLxd-pErTrRQZ2oVSdq1IkO6kTLiqI6PSCL46P59MQxDTecTHi8dQC4cOnnXlLA1uZpFKU8VAGTaZSLMAgUg_0u8rTAqm0uV0oBfBYsF1GYqShlOX9I9qq6Kh4TKn0lw8D1E-4mfu5KcFsFeBuJZCJLXakmRAyrF2emGj02RVnH6JXCqsfjqse46rHHYlz1CTkYn_vW12P56xMvB-HEYDoxHpZURd01mN0Ych4Bav3DPRhIBhjLvAl51At0nBc56OAf-RMit0Q93oCl27e_qcqVLuHOOWg2855c492ektt2cz0je-2mK54DEG7TF1qDfwIr0rVU |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Corticosteroid-dependent+plasticity+mediates+compulsive+alcohol+drinking+in+rats&rft.jtitle=The+Journal+of+neuroscience&rft.au=Vendruscolo%2C+Leandro+F&rft.au=Barbier%2C+Estelle&rft.au=Schlosburg%2C+Joel+E&rft.au=Misra%2C+Kaushik+K&rft.date=2012-05-30&rft.issn=1529-2401&rft.eissn=1529-2401&rft.volume=32&rft.issue=22&rft.spage=7563&rft_id=info:doi/10.1523%2FJNEUROSCI.0069-12.2012&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon |